Physicochemical and immunological effects of adjuvant formulations with snake venom antigens for immunization of horses for antivenom production.


Journal

Toxicon : official journal of the International Society on Toxinology
ISSN: 1879-3150
Titre abrégé: Toxicon
Pays: England
ID NLM: 1307333

Informations de publication

Date de publication:
15 Aug 2023
Historique:
received: 18 05 2023
revised: 19 07 2023
accepted: 21 07 2023
medline: 8 8 2023
pubmed: 27 7 2023
entrez: 26 7 2023
Statut: ppublish

Résumé

Enhancement of antivenom immune responses in horses through adjuvant technology improves antivenom production efficiency, but substantial local reactogenicity associated with some traditional veterinary adjuvants limits their usability. To explore modern adjuvant systems suitable for generating antivenom responses in horses, we first assessed their physicochemical compatibility with Bothrops asper snake venom. Liposome and nanoparticle aluminum adjuvants exhibited changes in particle size and phospholipid content after mixing with venom, whereas squalene emulsion-based adjuvants remained stable. Next, we evaluated serum antibody response magnitude and neutralization capacity in horses immunized with adjuvant-containing Echis ocellatus, Bitis arietans, Naja nigricollis, and Dendroaspis polylepis venom preparations. Whereas all tested adjuvants elicited significant neutralization capacity against the viperid venoms, the greatest antibody responses were generated by a squalene-in-water emulsion, thus representing a promising novel alternative for antivenom production.

Identifiants

pubmed: 37495191
pii: S0041-0101(23)00215-5
doi: 10.1016/j.toxicon.2023.107229
pii:
doi:

Substances chimiques

Antivenins 0
Emulsions 0
Squalene 7QWM220FJH
Snake Venoms 0
Adjuvants, Immunologic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107229

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Authors declare no Competing Non-Financial Interests but the following Competing Financial Interests. CBF and APK are inventors on patents and/or patent applications involving adjuvant formulations and methods featured here. All other authors declare they have no competing interests.

Auteurs

Christopher B Fox (CB)

Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA. Electronic address: christopher.fox@aahi.org.

Amit P Khandhar (AP)

Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.

Lisa Khuu (L)

Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.

Tony Phan (T)

Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.

Robert Kinsey (R)

Access to Advanced Health Institute (formerly Infectious Disease Research Institute), Seattle, WA, USA.

Daniel Cordero (D)

Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.

José María Gutiérrez (JM)

Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.

Guillermo León (G)

Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH